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0.004). Patients with clinically relevant depressive symptoms 
at discharge had a 2.5-fold increased relative risk of poor car-
diac prognosis compared to patients without clinically rele-
vant depressive symptoms independently of other prognos-
tic variables.  Conclusion: In patients with CVD, depressive 
symptoms at discharge from rehabilitation indicated a poor 
cardiac prognosis.  © 2015 S. Karger AG, Basel 
 Introduction 
 Cardiovascular disease (CVD) is the major cause of 
death in adults in developed countries  [1] . Even if the pa-
tient survives the first CVD event, there is a 43% chance 
of experiencing a recurrent CVD-related event in the first 
year  [2] . Psychosocial risk factors increase the risk of CVD 
independently of traditional cardiovascular risk factors 
(CVRFs)  [3, 4] . In particular, clinically relevant levels of 
depressive symptoms are prevalent among patients with 
CVD; for instance, 20% of myocardial infarction patients 
have major depression and another 20% have minor de-
pression  [5] . Depression does not only increase the risk of 
the first CVD event, but it may also act as a barrier to treat-
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 Abstract 
 Objectives: Depression is associated with poor prognosis in 
patients with cardiovascular disease (CVD). We hypothe-
sized that depressive symptoms at discharge from a cardiac 
rehabilitation program are associated with an increased risk 
of future CVD-related hospitalizations.  Methods: We exam-
ined 486 CVD patients (mean age =  59.8 ± 11.2) who enrolled 
in a comprehensive 3-month rehabilitation program and 
completed the depression subscale of the Hospital Anxiety 
and Depression Scale (HADS-D). At follow-up we evaluated 
the predictive value of depressive symptoms for CVD-relat-
ed hospitalizations, controlling for sociodemographic fac-
tors, cardiovascular risk factors, and disease severity.  Re-
sults: During a mean follow-up of 41.5 ± 15.6 months, 63 
patients experienced a CVD-related hospitalization. The per-
centage of depressive patients (HADS-D  ≥ 8) decreased from 
16.9% at rehabilitation entry to 10.7% at discharge. Depres-
sive symptoms at discharge from rehabilitation were a sig-
nificant predictor of outcome (HR 1.32, 95% CI 1.09–1.60; p = 
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ment efforts and to improving lifestyle  [3] . Meta-analyses 
emphasize the unfavorable impact of depression on the 
prognosis of patients with coronary heart disease (CHD) 
 [6, 7] . However, conclusions are limited by the heteroge-
neity of the reviewed studies. Literature also confirmed 
that cardiac rehabilitation programs reduce subsequent 
CHD events, the total mortality risk and depression by 
40–50%  [8, 9] . However, few studies have evaluated the 
predictive value of depression during rehabilitation in re-
lation to subsequent CVD-related hospitalizations.
 To our knowledge, no other studies to date have ana-
lyzed whether depression at discharge from cardiac reha-
bilitation is prospectively associated with an increased 
risk of subsequent CVD-related hospitalizations in a sam-
ple of patients with different primary diagnoses of CVD. 
We decided to focus on depressive symptoms at discharge 
from rehabilitation because we strived to exclude patients 
with spontaneously remitting depressive symptoms and/
or those with a short-term depressive adjustment disorder 
in response to a CVD event  [10] . Additionally, previous 
studies have shown that CHD patients whose depression 
scores do not improve during cardiac rehabilitation or 
psychotherapy are at a higher mortality risk compared to 
patients who respond to treatment  [9, 11] .
 We performed a prospective study with patients who had 
participated in a cardiac rehabilitation program and exam-
ined their depression scores at discharge from the program 
with respect to future CVD-related hospitalizations. We hy-
pothesized that depression is an independent predictor of 
CVD-related hospitalizations after controlling for demo-
graphic variables, traditional CVRFs and disease severity.
 Methods 
 Participants and Design 
 All study patients participated in a comprehensive outpatient 
cardiac rehabilitation program at the Bern University Hospital, 
Switzerland, and were enrolled between January 2004 and 
 December 2010. A detailed overview of the rehabilitation program 
has previously been published  [12] . We included patients with a 
diagnosis of CVD (i.e., CHD, chronic heart failure and aortic valve 
surgery) who filled out a set of questionnaires during the first week 
and at discharge of an 8- to 12-week cardiac rehabilitation pro-
gram. All patients provided written informed consent. The local 
ethics committee approved the study protocol. Demographic and 
medical data were obtained from hospital charts and through 
physical examination at the beginning of rehabilitation. The flow-
chart ( fig. 1 ) illustrates the recruitment process for the patients. 
For the analysis we selected 486 patients from a total of 777 eligible 
patients. The group of patients who dropped out for reasons which 
are detailed in  figure 1 did not significantly differ in terms of sex, 
age and educational background from the final study sample.
 Assessment of the Main Outcome Measure and Covariates 
 Depression was measured with the validated German version 
of the Hospital Anxiety and Depression Scale (HADS-D), which 
comprises seven items to assess the severity of depressive symp-
toms  [13] . Patients have to rate on a 4-point Likert scale the symp-
tom frequency (range from 0 = ‘mostly’ to 3 = ‘not at all’) with 
reference to the last week, yielding a total depressive symptom 
score ranging from 0 to 21. In the present study a cutoff value of 8 
points on the HADS-D scale was used to categorize the patients 
into two groups with high (score  ≥ 8) versus low (score <8) depres-
sive symptom scores. We selected this cutoff value because it has 
previously been shown to optimally identify cases of depression 
with a mean sensitivity of 0.83 and a mean specificity of 0.79  [14] .
 We obtained information about sex, age, educational back-
ground and disease severity in the first week of the rehabilitation 
program. Traditional CVRFs were assessed while taking a medical 
history at the beginning and at discharge of the rehabilitation pro-
gram. Body mass index was calculated on the basis of measured 
weight and height (kg/m 2 ). A body mass index  ≥ 30 indicates obe-
sity and was defined as a CVRF. Further CVRFs were diabetes, 
hypercholesterolemia, current smoking, a positive family history 
of CHD, and hypertension.
 Assessment at Follow-Up 
 The follow-up period was defined as the time period between 
the discharge from the rehabilitation program and the semistruc-
tured telephone interview. The purpose of the telephone interview 
was to assess whether the patient has been rehospitalized due to a 
CVD-related event since discharge from the rehabilitation pro-
Eligible data
(n = 777)
Dropout
- Missing admission questionnaire (n = 157)
- Missing discharge questionnaire (n = 74)
- CVD event during rehabilitation (n = 4)
Patients contacted
for follow-up
(n = 542)
Patients reached
(n = 508)
Patients not reached
(e.g. invalid phone number) (n = 34)
Dropout
- Deceased (n = 9)
- Too many missing variables (n = 9)
- Not interested in participating (n = 4)
Final sample
(n = 486)
 Fig. 1. Flowchart of patients selected for analysis. 
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gram. If a patient confirmed to have suffered a subsequent CVD-
related event, his or her primary care physician was contacted by 
phone and asked to send in a copy of the medical records for veri-
fication of the event. A total of 25 diagnostic categories and inter-
ventions were considered as subsequent CVD-related events.
 Statistical Analysis 
 Data were analyzed using the SPSS 21.0 statistical software 
package (SPSS Inc., Chicago, Ill., USA) with a significance level of 
p  < 0.05 (two-tailed). For the imputation of missing variables 
(<5%) we applied the expectation maximum algorithm  [15] . The 
Kolmogorov-Smirnoff test indicated a skewed distribution to-
wards small values. However, no normal distribution was pursued 
because skewed predictors do not have an impact on regression-
type models  [16] . Group differences in variables between patients 
with high versus low depressive symptom scores were calculated 
with the Mann-Whitney test.
 For the main analysis we ran Cox proportional hazard models 
in order to define the predictive value of continuously and dichot-
omously scaled HADS-D scores for the relative risk of the end-
point hospitalizations due to a CVD-related event during follow-
up. In the analysis with continuous HADS-D scores, the relative 
risk describes the predictive risk of scoring one point higher on the 
depression scale. A one-point interval is unlikely to be clinically 
relevant. Therefore, we expressed the change in the hazard ratio 
for a three-point higher level on the depression scale, marking 
transitions between mild, moderate and severe depression. Spe-
cifically, depression scores can be divided into four ranges of mood 
severity  [17] . Scores 0–7 indicate no depression, 8–10 mild depres-
sion, 11–14 moderate depression and scores above 14 represent 
severe depression. We calculated the three-point interval by divid-
ing the continuously scaled depression score by three and used the 
obtained measure in our analysis. Control variables for the model 
were defined a priori. As previously suggested, to prevent model 
overfitting given the number of CVD-related events, we performed 
data collapsing for CVRFs, whereby we assigned one point each for 
obesity, diabetes, hypercholesterolemia, current smoking, positive 
family history, and hypertension  [16] . For the analysis, these points 
were added up to form a total CVRF score ranging from 0 to 6. The 
final model was adjusted for sex, age, educational background, the 
CVRF score obtained at discharge from rehabilitation, and disease 
severity (i.e., the number of diseased vessels).
 We performed two supplemental analyses. We calculated a 
complementary analysis adding each individual CVRF separately 
to the model because the collapsing of the traditional CVRFs into 
one sum score might obscure the predictive value of individual 
CVRFs. For a sensitivity analysis we excluded patients who suffered 
from endocarditis, pericarditis or pulmonary embolism as an out-
come because these are not traditionally considered CVD events.
 Results 
 Patient Characteristics 
 Except depressive symptom scores, there were no rel-
evant changes in patient characteristics between rehabili-
tation entry and discharge, as best medical/cardiology 
treatment was already initiated in the acute care setting 
(data not shown in detail). Depression symptom scores 
significantly dropped from rehabilitation entry to dis-
charge from rehabilitation (4.2 ± 3.5, range 0–17, vs. 3.3 ± 
3.3, range 0–20, p  < 0.001). High depressive symptom 
scores (i.e., HADS-D scores  ≥ 8) were found in 16.9% of 
patients at rehabilitation entry and in 10.7% of patients at 
discharge from rehabilitation.  Table 1 shows the charac-
teristics of the total sample of patients at discharge from 
rehabilitation and for the two groups scoring high versus 
low in depressive symptoms.
 Cardiovascular Events during Follow-Up 
 On average the follow-up telephone interview was 
conducted 41.5 ± 13.6 months (range 12–80) after dis-
charge from rehabilitation. Of the 486 patients, 63 (12.9%) 
experienced a CVD-related hospitalization during the 
follow-up period from which 5 patients had died (7.9%). 
The CVD-related event occurred, on average, 20.9 ± 16.0 
months (range 0.5–67) after discharge from rehabilita-
tion. Sixteen different CVD-related events resulting in 
hospitalization were registered; these were elective intra-
coronary stenting (42.8%), nonelective intracoronary 
stenting (11.1%), cardiac arrhythmias (6.3%), cerebro-
vascular insult (6.3%), sudden cardiac arrest (6.3%), pace-
maker implantation (4.7%), nonelective coronary angi-
ography without stenting (3.2%), chronic heart failure 
(3.2%), pulmonary embolism (3.2%), endocarditis (3.2%), 
coronary artery bypass surgery (1.6%), hypertensive crisis 
(1.6%), aneurysm (1.6%), Takotsubo cardiomyopathy 
(1.6%), pericarditis (1.6%), conduit change (1.6%) and 
cardiac mortality (7.9%).
 Cox Regression Model 
 Depressive symptoms at discharge from rehabilitation 
were a significant predictor of future CVD-related events 
(HR 1.32, 95% CI 1.09–1.60; p = 0.004). Thus, patients 
scoring three points higher on the depression scale had a 
32% higher risk of experiencing a subsequent CVD-relat-
ed hospitalization. The covariates sex, age, education, 
CVRF score and disease severity at discharge from reha-
bilitation did not emerge as independent predictors.
 We ran a complementary analysis to possibly identify a 
predictive value of individual CVRFs that might have been 
obscured by collapsing all CVRFs across one sum score. 
This analysis showed that none of the CVRFs (i.e., diabetes, 
positive family history, hypertension, hypercholesterol-
emia, adiposity, current smoking) were independently 
predictive for subsequent CVD-related hospitalizations.
 Performing a sensitivity analysis, we excluded 5 pa-
tients who had experienced pericarditis, endocarditis, or 
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pulmonary embolism after discharge from rehabilitation 
as these outcomes are not traditionally considered CVD 
events. In this sensitivity analysis depressive symptoms at 
discharge from rehabilitation maintained their signifi-
cant predictive value for CVD-related hospitalizations 
(HR 1.40, 95% CI 1.15–1.69; p = 0.001).
 In a final analysis we used the cutoff for clinically rel-
evant levels of depressive symptoms as the predicting vari-
able of interest. Individuals were grouped into patients 
with high depressive symptom scores (HADS-D score  ≥ 8) 
versus those with low depressive symptom scores (HADS-
D score <8). Patients with high depressive symptom scores 
at discharge had a 2.5-fold increased relative risk of expe-
riencing a CVD-related hospitalization (HR 2.57, 95% CI 
1.42–4.63; p = 0.002). The model was adjusted for sex, age, 
education, CVRF score, and disease severity.
 Discussion 
 We found that depression scores during a comprehen-
sive outpatient cardiac rehabilitation program predicted 
future CVD-related hospitalizations over a mean follow-
up period of almost 3.5 years. This association was inde-
pendent of other potentially important predictors of poor 
prognosis in patients with CVD. Our results show that in 
a sample of 486 patients, 82 (16.8%) patients scored high 
on the depression score at the beginning of rehabilitation, 
a number that concurs with previous research  [9, 18] . 
Upon completion of rehabilitation, only 10.7% of the pa-
tients suffered from a clinically relevant depression. By 
trend, patients in our study who had high levels of depres-
sive symptoms were younger than those with low levels 
of depressive symptoms, concurring with findings by La-
vie and Milani  [19] . Younger CVD patients might be 
prone to depression because CVD manifests less fre-
quently at a young age, whereas elderly patients might 
rather perceive CVD as part of normal ageing. Although 
not assessed in our study, younger patients might also 
have worse general health and health behaviors, includ-
ing more sedentary behavior and unhealthy nutrition, 
both potentially increasing the level of depressive symp-
toms but also increasing the risk of premature CVD.
 Depression was independently predictive of CVD-re-
lated hospitalizations in patients after cardiac rehabilita-
tion. The continuous depression score demonstrated a 
 Table 1.  Patient characteristics by depression level on the HADS at discharge (cutoff ≤8)
Variable Total sample
(n = 486)
High HADS score
(n = 52)
Low HADS score
(n = 434)
p value
Age (mean ± SD), years 59.8±11.2 57.4±11.4 60.2±11.3 0.051
Male gender, % 78.0 75.0 78.3 0.583
Highest level of education, % 0.944
Primary school 5.5 9.6 5.1
Vocational training 68.3 61.5 69.1
College or university 26.1 28.8 25.8
Diabetes, % 12.6 17.3 12.0 0.274
Hypercholesterolemia, % 65.2 71.2 64.5 0.343
Smoking, % 40.3 46.2 39.6 0.365
Hypertension, % 61.1 61.5 61.1 0.947
Positive family history, % 30.9 21.2 32.0 0.109
Obesity, % 18.7 21.2 18.4 0.635
Vessel disease, % 0.583
0-vessel disease 16.5 13.5 16.8
1-vessel disease 33.3 34.6 33.2
2-vessel disease 20.8 19.2 21.0
3-vessel disease 29.2 32.7 28.8
Aspirin, % 86.4 86.5 86.4 0.979
Beta-blockers, % 82.5 86.5 82.0 0.419
Statins, % 84.2 78.8 84.8 0.268
Diuretics, % 18.9 28.8 17.7 0.054
Angiotensin-converting enzyme inhibitor, % 61.9 61.5 62.0 0.950
Plavix, % 56.4 57.7 56.2 0.840
Depression score (mean ± SD) 3.3±3.3 10.5±2.4 2.4±2.1 <0.001
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dose-response relationship between the severity of de-
pressive symptoms and poor outcome. Also Lespérance 
et al.  [20] showed that the overall level of depressive 
symptoms predicted cardiac mortality in patients with 
CHD after a 5-year follow-up. Our findings that depres-
sive symptom scores even below a clinically relevant cut-
off are adversely associated with the prognosis of patients 
with CVD concur with results from two meta-analyses. 
According to Barth et al.  [6] , depressed CHD patients are 
at a twofold risk of dying in the subsequent 2 years. The 
investigation of 22 studies by van Melle et al.  [7]  came to 
similar conclusions. Most of the previous studies collect-
ed fatal endpoints but less so hospitalization data in rela-
tion to the predictive value of depression. Moreover, de-
pression was measured solely after hospital admission 
and not in the context of a cardiac rehabilitation program. 
Therefore, our study design differs in several points from 
the bulk of prognostic studies in depressed cardiac pa-
tients and provides novel data. Furthermore, we focused 
on depression scores at discharge of the program, so we 
could consider spontaneous remission of depressive 
symptomatology, for instance as part of a short-term ad-
justment disorder  [10] . Previous studies have also shown 
that especially patients whose depression scores do not 
improve in response to treatments, including cardiac re-
habilitation, have a poorer prognosis than patients who 
were only depressed at the beginning of rehabilitation  [9, 
11] . Also, another study found that depressed CVD pa-
tients who did not respond to treatment with the antide-
pressant mirtazapine were at higher risk of experiencing 
a CVD-related event  [21] .
 There are several limitations of our study that deserve 
mention. We included patients who were able to partici-
pate in a cardiac outpatient rehabilitation program. This 
might produce a selection bias because the severity of the 
CVD, the depression level and motivation might influ-
ence participation. Therefore, the study results cannot be 
transferred to other cardiac patients, including those with 
greater physical and mental impairment. Furthermore, 
we did not statistically control for further potential pre-
dictors, e.g. medication, physical activity, and adherence 
to therapy in order to avoid model overfitting. Control-
ling for such variables would have added strength to our 
study findings. In order to limit the burden on patients, 
we applied only one scale to measure depressive symp-
toms. Had we shown similar results with different mea-
surements for depressive symptoms, this would have 
strengthened the validity of our results. As part of the 
comprehensive exercise-based cardiac rehabilitation pro-
gram, patients participated in a stress management group. 
No further systematic treatments that specifically reduce 
depression were provided. However, a meta-analysis by 
Rutledge et al.  [8] confirmed that exercise-based cardiac 
rehabilitation treatments and mental health therapies 
(i.e., psychotherapies and antidepressants) showed simi-
lar effects on depression severity in patients with CHD. 
The present study is the first to investigate an association 
of depression with postrehabilitation outcomes in a sam-
ple of patients with three different primary diagnoses of 
CVD (i.e., CHD, chronic heart failure and aortic valve 
surgery). Studying this heterogeneous sample was justi-
fied because all patients completed the same rehabilita-
tion program and only on top received information and 
therapeutic elements that were specifically tailored for 
each diagnosis of CVD. For further studies we recom-
mend considering a control group as this might strength-
en the significance of the findings.
 In conclusion, depressive symptoms during rehabili-
tation predicted future CVD-related hospitalizations 
during a follow-up period of 3.5 years. We observed a 
dose-response relationship between depression scores 
and risk of a subsequent CVD-related event. Addition-
ally, depressive symptom scores were reduced during re-
habilitation. Therefore, cardiac rehabilitation programs 
might benefit patients’ cardiovascular prognosis if an em-
phasis is put on reducing depressive symptoms during 
rehabilitation through effective means.
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